Johnson & Johnson Consumer and Personal Products Worldwide

Ownership
Private
Employees
-
Market Cap
-
Website

Study to Evaluate Diphenhydramine in Children and Adolescents

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-09-30
Last Posted Date
2011-10-06
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
36
Registration Number
NCT00762749
Locations
🇺🇸

Arkansas Medical Research Testing Center, Little Rock, Arkansas, United States

Phenylephrine Pediatric Pharmacokinetic Study

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-09-30
Last Posted Date
2011-10-06
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
36
Registration Number
NCT00762567
Locations
🇺🇸

West Coast Clinical Trials, Cypress, California, United States

Study to Determine the Best Way to Measure How Quickly the Drug Can Give Relief From Sudden Diarrhea

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-05-28
Last Posted Date
2011-10-06
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
45
Registration Number
NCT00685607
Locations
🇲🇽

Universidad Autonoma de Guadalajara, Guadalajara, Jalisco, Mexico

Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-04-21
Last Posted Date
2011-09-08
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
36
Registration Number
NCT00662337

To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses

First Posted Date
2008-04-01
Last Posted Date
2011-08-22
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
1021
Registration Number
NCT00648973
Locations
🇺🇸

Sun Research Institute, San Antonio, Texas, United States

🇺🇸

Biogenics Research Institute, San Antonio, Texas, United States

🇺🇸

Diagnostics Research Group, San Antonio, Texas, United States

and more 9 locations

An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee

Phase 3
Completed
Conditions
First Posted Date
2005-10-18
Last Posted Date
2011-06-29
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
483
Registration Number
NCT00240786
© Copyright 2024. All Rights Reserved by MedPath